- Medical Malpractice
- Product
- Unsafe Drugs
- Bisphosphonate Litigation
- Bextra Litigation
- Silicone Gel Breast Implant Litigation
- Fen-Phen Diet Drugs
- Guidant Defibrillators
- Hormone Replacement Drugs
- Kugel Hernia Mesh Patches
- Medtronic Sprint Fidelis Lead
- Mentor ObTape Trans-Obturator Tape Litigation
- Ortho Evra Birth Control Patch
- Bausch & Lomb's ReNu with MoistureLoc Contact Lens Solution
- Vioxx Litigation
- Shoulder Pain Pumps
- Medtronic Defibrillator Litigation
- Other/Archive Drug Products
- Personal Injuries
- Auto Accidents
- Nursing Home Abuse
Wyeth to Appeal HRT Verdict in Arkansas
On March 6, 2008, Wyeth announced that it would appeal the verdict in Donna Scroggin v. Wyeth in the U.S. District Court, Eastern District of Arkansas. The plaintiff sued the manufacturers of Premarin and Prempro relating to her development of breast cancer. On February 25, 2008, the jury awarded the plaintiff $2.75 million in compensatory damages against Wyeth and co-defendant Upjohn. After a second phase of the trial relating to punitive damages, the jury awarded Ms. Scroggin $19.36 million against Wyeth and $7.76 million against Upjohn.